# US 2016/0250179 A1 · Composition for suppressing neuraminidase activity comprising geranylated flavonoid derived from paulownia tomentosa as active ingredient

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0250179 A1
- Document ID: US20160250179A1
- Status: Published application
- Kind: A1
- Application number: 14/908,544
- Filed: 2014-07-25
- Published: 2016-09-01
- Earliest claimed: 2013-07-29
- Assignees: Industry-Academic Cooperation Foundation Gyeongsang National University; Gwangju Institute of Science and Technology
- Applicants: Industry-Academic Cooperation Foundation Gyeongsang National University; Gwangju Institute of Science and Technology
- Inventors: Ki Hun PARK; Soo Hyun EOM; Young Bae RYU; Jung Keun CHO
- Web page: https://patentgrep.com/patent/US20160250179A1

## CPC

- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/80: Scrophulariaceae (Figwort family)
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 31/16: for influenza or rhinoviruses
- A61K 2236/33: involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a composition for suppressing neuraminidase activity comprising a geranylated flavonoid derived from Paulownia tomentosa as an active ingredient. The Paulownia tomentosa extract and the geranylated flavonoid isolated therefrom exhibit an effect in significantly suppressing neuraminidase, which is an enzyme that plays an important role in the occurrence of pathogenic viral and bacterial infections and of the inflammation that accompanies such infection, and thus the Paulownia tomentosa extract or the geranylated flavonoid isolated therefrom can advantageously be used as an active ingredient in a composition for inhibiting neuraminidase activity.

## Claims

### Claim at position 1

1-32. (canceled)

### Claim 33

A method for inhibiting neuraminidase activity, comprising administering administering a pharmaceutically effective amount of an extract of Paulownia tomentosa or a fraction thereof to an individual.

### Claim 34 (depends on 33)

The method for inhibiting neuraminidase activity according to claim 33, wherein the extract of Paulownia tomentosa is extracted using water, alcohols or a mixture thereof.

### Claim 35 (depends on 34)

The method for inhibiting neuraminidase activity according to claim 34, wherein the alcohol is a C1 to C2 lower alcohol.

### Claim 36 (depends on 35)

The method for inhibiting neuraminidase activity according to claim 35, wherein the lower alcohol is ethanol or methanol.

### Claim 37 (depends on 33)

The method for inhibiting neuraminidase activity according to claim 33, wherein the neuraminidase is derived from viruses, bacteria or humans.

### Claim 38 (depends on 37)

The method for inhibiting neuraminidase activity according to claim 37, wherein the virus is influenza A virus subtype H1N1, influenza B virus subtype H1N1, or influenza C virus subtype H1N1.

### Claim 39 (depends on 37)

The method for inhibiting neuraminidase activity according to claim 37, wherein the bacteria are Clostridium perfringens.

### Claim 40

A method for inhibiting neuraminidase activity, comprising administering a pharmaceutically effective amount of a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof to an individual.
wherein R1 is —H, —OH or a C1-3 linear or branched alkoxy, R2 is —OH or a C1-3 linear or branched alkoxy, R3 is —H, —OH or a C1-3 linear or branched alkoxy, and R4 is —H or —OH.

### Claim 41 (depends on 40)

The method for inhibiting neuraminidase activity according to claim 40, wherein the compound represented by Formula 1 is one selected from the group consisting of Formulae 2 to 10:

### Claim 42 (depends on 40)

The method for inhibiting neuraminidase activity according to claim 40, wherein the compound represented by Formula 1 is derived from Paulownia tomentosa.

### Claim 43

A method for treating viral or bacterial inflammatory diseases comprising administering a pharmaceutically effective amount of a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof.
wherein R1 is —H, —OH or a C1-3 linear or branched alkoxy, R2 is —OH or a C1-3 linear or branched alkoxy, R3 is —H, —OH or a C1-3 linear or branched alkoxy, and R4 is —H or —OH.

### Claim 44 (depends on 43)

The method for inhibiting neuraminidase activity according to claim 43, wherein the compound represented by Formula 1 is one selected from the group consisting of Formulae 2 to 10:

### Claim 45 (depends on 43)

The method for inhibiting neuraminidase activity according to claim 43, wherein the compound represented by Formula 1 is derived from Paulownia tomentosa.
